The opportunity to deliver better health for a better world by providing people access to high quality medicine is an honor and a privilege for Mylan. Consistent with our company’s unconventional nature, we don’t refer to health in just the traditional sense. Instead, we want to help people everywhere enjoy physical, mental, economic and relational well-being so they can thrive and give back to their communities.
Achieving this goal informs everything we do. It’s why we are willing to challenge the status quo. It’s why we continue to insist on “doing what’s right, not what’s easy,” our co-founders’ mantra. It’s why we continue to strive to serve all our stakeholders and have built Mylan to last. Making the world a better place also is why Mylan is stepping up its efforts to reimagine and transform healthcare in ways that we hope will serve generations to come. This report is serving as a roadmap for our work.
For instance, we have been expanding our efforts to analyze Mylan’s most relevant ESG practices and data, and better understand our stakeholders’ evolving expectations about a broad range of associated topics. Further, to use this knowledge to inform decisions and actions across our organization, we created in 2017 an executive role of head of Global Sustainability. This role is part of my executive governance team. Working in coordination with a multidisciplinary group, this leader is responsible for overseeing the development and execution of Mylan’s goals on relevant ESG topics. The function provides an important channel for additional engagement with Mylan’s stakeholders.
Mylan also signaled its continued commitment to sustainability by signing on in 2017 to the U.N. Global Compact. We joined the AMR Industry Alliance and signed the Davos Declaration on AMR; both actions reflect our dedication to the fight against the rise of antimicrobial resistance (AMR). We also made our first submission to CDP, a not-for-profit organization that runs the global disclosure system for investors, companies, cities, states and regions to manage their environmental impacts.
In addition, we entered into a landmark agreement with UNAIDS, the Bill & Melinda Gates Foundation, the Clinton Health Access Initiative and other partners to provide the next-generation single-pill HIV regimen to patients in more than 90 low- and middle-income countries for less than $75 per person per year. Further, we formalized our commitment to the U.N.’s Every Woman Every Child initiative as part of our participation in the 2017 Family Planning 2020 (FP2020) summit. These and many other examples of our commitment and leadership are included throughout this report.
2017 also presented challenges for our industry and our business. As debates continued around the globe about prescription-drug prices and the growing devastation caused by opioid addiction, particularly in the U.S., we considered our role and how we can help address these issues in ways that best reflect our mission.
Additionally, our rapidly evolving industry, as well as the need to maintain our diversified, durable and access-focused business model, continue to challenge us to provide an efficient and effective ONE Mylan organization. Consistently adapting our operations is essential if we are to remain competitive in today’s global marketplace.
As always, Mylan learns from our experiences. Clearer than ever, for instance, is the importance of proactively engaging with our various stakeholders. We recognize the need to help others understand our story of commitment to access and to hear their perspectives on how we can continue to learn and grow. That’s why stakeholder engagement is among my priorities for 2018. Another priority is to demonstrate, through our actions, Mylan’s ongoing support for the U.N. Global Compact and its 10 principles.
The bottom line is that serving our stakeholders is Mylan’s business. Their trust and support are essential to our success and ability to deliver better health for a better world. On behalf of the company’s board of directors and senior leadership team, I’d like to thank everyone – and particularly Mylan’s workforce – for sharing our commitment to constructive change, to excellence and to the incredible potential that only cooperation and inspiration across borders, cultures and individual differences can realize.